Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 6:19 pm Purchase | 2023-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital, LLC | 6,275,210 8.900% | 2,857,142 (+83.59%) | Filing History |
| 2024-02-14 6:12 pm Sale | 2023-12-31 | 13G | NGM Biopharmaceuticals, Inc. NGM | EcoR1 Capital, LLC | 2,385,873 2.900% | -4,049,645 (-62.93%) | Filing History |
| 2024-02-14 6:05 pm Purchase | 2023-12-18 | 13G | Neurogene Inc. NGNE | EcoR1 Capital, LLC | 1,282,168 9.990% | 1,282,168 (New Position) | Filing History |
| 2024-02-14 5:58 pm Purchase | 2023-12-31 | 13G | Kura Oncology, Inc. KURA | EcoR1 Capital, LLC | 7,598,797 9.990% | 960,426 (+14.47%) | Filing History |
| 2024-02-14 5:53 pm Sale | 2023-12-31 | 13G | Janux Therapeutics, Inc. JANX | EcoR1 Capital, LLC | 0 0.000% | -3,255,270 (Position Closed) | Filing History |
| 2024-02-14 5:47 pm Sale | 2023-12-31 | 13G | HOOKIPA Pharma Inc. HOOK | EcoR1 Capital, LLC | 459,502 4.800% | -37,847 (-7.61%) | Filing History |
| 2024-02-14 5:41 pm Unchanged | 2023-12-31 | 13G | Galapagos N.V. GLPG | EcoR1 Capital, LLC | 6,505,890 9.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 5:37 pm Purchase | 2023-12-31 | 13G | Centessa Pharmaceuticals plc CNTA | EcoR1 Capital, LLC | 5,618,779 5.800% | 386,500 (+7.39%) | Filing History |
| 2024-02-14 5:24 pm Purchase | 2023-12-31 | 13G | Arvinas, Inc. ARVN | EcoR1 Capital, LLC | 6,800,493 9.990% | 3,677,193 (+117.73%) | Filing History |
| 2024-02-14 5:18 pm Purchase | 2023-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | EcoR1 Capital, LLC | 11,173,068 9.400% | 4,865,521 (+77.14%) | Filing History |
| 2024-02-14 5:07 pm Purchase | 2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | EcoR1 Capital, LLC | 290,566 9.990% | 132,631 (+83.98%) | Filing History |
| 2024-02-14 4:37 pm Purchase | 2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | EcoR1 Capital, LLC | 887,076 2.500% | 887,076 (New Position) | Filing History |
| 2024-02-14 4:27 pm Sale | 2023-12-31 | 13G | Adicet Bio, Inc. ACET | EcoR1 Capital, LLC | 0 0.000% | -222,544 (Position Closed) | Filing History |
| 2024-02-14 4:15 pm Sale | 2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO | EcoR1 Capital, LLC | 1,086,956 4.200% | -698,707 (-39.13%) | Filing History |
| 2024-02-01 5:11 pm Purchase | 2024-01-22 | 13G | AlloVir, Inc. ALVR | EcoR1 Capital, LLC | 463,277 9.300% | 463,277 (New Position) | Filing History |
| 2024-01-30 5:26 pm Purchase | 2024-01-30 | 13G | Adaptimmune Therapeutics plc ADAPY | EcoR1 Capital, LLC | 113,424,420 7.700% | 113,424,420 (New Position) | Filing History |
| 2023-12-27 4:05 pm Purchase | 2023-12-18 | 13G | Mirati Therapeutics, Inc. MRTX | EcoR1 Capital, LLC | 7,396,979 10.500% | 1,648,580 (+28.68%) | Filing History |
| 2023-11-20 7:00 pm Purchase | 2023-11-16 | 13G | Atara Biotherapeutics, Inc. ATRA | EcoR1 Capital, LLC | 402,682 9.900% | 402,682 (New Position) | Filing History |
| 2023-10-16 3:33 pm Purchase | 2023-10-13 | 13G | Tango Therapeutics, Inc. TNGX | EcoR1 Capital, LLC | 13,330,736 13.100% | 5,503,100 (+70.30%) | Filing History |
| 2023-10-12 12:25 pm Purchase | 2023-10-02 | 13G | Immunome, Inc. IMNM | EcoR1 Capital, LLC | 3,879,415 9.100% | 3,879,415 (New Position) | Filing History |